| 000 | 01865cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030255.0 | ||
| 008 | 100915s2010 ua h f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2010.Ma.P | ||
| 100 | 0 | _aMahmoud Aly Mohamed Ayoub | |
| 245 | 1 | 0 |
_aPrognostic significance of molecular markers in acute myeloid leukemia Essay / _cMahmoud Aly Mohamed Ayoub ; Supervised Safaa Mostafa Elkaraksy , Nahed Abdelwahab Mohamed , Maha Abdelhamid Eltaweel |
| 246 | 1 | 5 | _aأهمية الدلالات الجزيئية فى التطور المرضى لسرطان الدم الميلودى الحاد |
| 260 |
_aCairo : _bMahmoud Aly Mohamed Ayoub , _c2010 |
||
| 300 |
_a177 P. : _bfacsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aMolecular markers; molecular genetic alterations are of high predictive and prognostic significance in acute myeloid leukemia (AML) especially in AML patients with normal karyotype which is the target subgroup in AML. They are providing targets for molecular therapy. The identification of molecular genetic alterations such as gene mutations or deregulated gene expression in acute myeloid leukemia (AML), has greatly advanced our understanding of leukemogenesis | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAcute myeloid leukemia | |
| 653 | 4 | _aCytogenetically normal AML | |
| 653 | 4 | _aMolecular markers | |
| 700 | 0 |
_aMaha Abdelhamid Eltaweel , _eSupervisor |
|
| 700 | 0 |
_aNahed Abdelwahab Mohamed , _eSupervisor |
|
| 700 | 0 |
_aSafaa Mostafa Elkaraksy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c31299 _d31299 |
||